Dental amalgam controversy
Dental amalgam controversy refers to the ongoing debate over the use of dental amalgam in dental restorations. Dental amalgam is a type of dental filling material that is made from a mixture of different metals, including mercury, silver, tin, and copper. Despite its long history of use, concerns have been raised about the potential health risks associated with the mercury content in dental amalgam.
History[edit]
The use of dental amalgam dates back to the 19th century. However, the controversy surrounding its use began in the late 20th century when concerns were raised about the potential health risks associated with the mercury content in dental amalgam.
Health concerns[edit]
The primary health concern associated with dental amalgam is the potential for mercury poisoning. Mercury is a toxic metal that can cause a variety of health problems, including neurological damage, kidney damage, and developmental problems in children. However, the amount of mercury released from dental amalgam is very small, and many studies have found no evidence of significant health risks associated with its use.
Alternatives to dental amalgam[edit]
There are several alternatives to dental amalgam available, including composite resin, glass ionomer cement, and gold. These materials do not contain mercury and are therefore considered to be safer alternatives.
Regulation[edit]
In many countries, the use of dental amalgam is regulated by government agencies, such as the Food and Drug Administration in the United States. These agencies have generally concluded that dental amalgam is safe for use in most people, although some have recommended limiting its use in certain populations, such as pregnant women and children.
Conclusion[edit]
While the dental amalgam controversy continues, it is important for patients to discuss the risks and benefits of different dental restoration materials with their dentist. This will allow them to make an informed decision about their dental health.
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian


